China Pharma Holdings (CPHI) Income from Non-Controlling Interests (2012 - 2015)
China Pharma Holdings (CPHI) posted Income from Non-Controlling Interests of $1.4 million for Q2 2015, up 116.33% on a QoQ basis from -$8.5 million in Q2 2014, and up 116.33% year-over-year from $640928.2 in Q2 2014.
China Pharma Holdings (CPHI) Income from Non-Controlling Interests (2012 - 2015) Analysis & Trends
China Pharma Holdings' Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at $1.4 million for Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 395,346.10 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -12.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 1.39 Mn |
| Jun 30, 2014 | -8.49 Mn |
| Sep 30, 2013 | -1.42 Mn |
| Sep 30, 2012 | 1.17 Mn |